Clinical trial
Alendronate Osteoporosis Study
NCT00277251 · Boston Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00277251 |
|---|---|
| Title | Alendronate Osteoporosis Study |
| Official title | Double-Blinded Controlled Trial of Alendronate for the Treatment of Childhood and Adolescent Glucocorticoid- Associated Osteopenia and Osteoporosis |
| Lead sponsor | Boston Children's Hospital, Other |
| Collaborators | Glaser Pediatric Research Network Elizabeth Glaser Pediatric AIDS Foundation |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Glucocorticoid-Associated Osteopenia and Osteoporosis |
| Intervention type | Drug |
| Interventions | Alendronate |
| Enrollment | 20 |
| Start date | Mar 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Jan 16, 2006 |
| Last update posted | Apr 11, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: